There are currently 154 active clinical trials seeking participants for Cardiovascular Diseases research studies. The states with the highest number of trials for Cardiovascular Diseases participants are Florida, California, Texas and New York.
Effect of Korean Red Ginseng Extract on Blood Flow in Healthy Adults
Recruiting
The objectives of this clinical trial are to 1) determine the effect of the TP compared to placebo on blood flow and platelet aggregation, 2) to determine the effect of the TP on cardiovascular health compared to a placebo and 3) to assess the safety and tolerability of the TP in healthy adults.
Gender:
All
Ages:
Between 20 years and 75 years
Trial Updated:
02/07/2024
Locations: Valiance Clinical Research, Tarzana, California
Conditions: Cardiovascular Diseases, Blood Pressure Disorders, Vasodilation, Platelet Aggregation
Wellness Intervention for Smoking and HIV
Recruiting
The investigators propose to use a parallel group, randomized controlled trial to test the efficacy of a 13-week personalized approach to reducing smoking intervention versus a second approach using a different health intervention on smoking cessation, healthy sleep metrics, and biomarkers of cardiovascular risk in a sample of 200 treatment-seeking smokers who are adults living with HIV (ALHIV). To enroll in the study, treatment-seeking ALHIV smokers will undergo phone and in-person study eligib... Read More
Gender:
All
Ages:
Between 18 years and 75 years
Trial Updated:
02/06/2024
Locations: Banner University Medical Center Phoenix, Phoenix, Arizona +1 locations
Conditions: HIV, Sleep, Smoking Cessation, Cardiovascular Diseases
Mitochondria Oxidative Stress and Vascular Health Study
Recruiting
Cardiovascular diseases (CVDs) are the number one cause of death in America and most of the post-industrial world. Hypertension is a leading risk factor for CVDs including stroke, myocardial infarction, and heart failure. Black Americans suffer from the highest rates of hypertension of any racial/ethnic group in America, among the highest in the world. There are also well-documented racial disparities in vascular dysfunction (e.g., endothelial dysfunction, arterial stiffening). Thus, racial disp... Read More
Gender:
All
Ages:
Between 45 years and 75 years
Trial Updated:
01/29/2024
Locations: Auburn University, Auburn, Alabama
Conditions: Cardiovascular Diseases, Hypertension, Racism, Vascular Diseases
Impact of Patient-Centered Approach for Communicating Coronary Calcium on Cardiovascular Health
Recruiting
This multicenter clustered randomized prospective study will be managed by the American College of Radiology Center for Research and Innovation (ACR CRI). The research team aims to test the efficacy of a patient-centered educational intervention based on coronary artery calcification (CAC) information in cardiovascular risk factor modification of a cohort of patients enrolled in lung cancer screening (LCS) programs across the country.
Gender:
All
Ages:
Between 50 years and 80 years
Trial Updated:
01/22/2024
Locations: University of Michagan, Ann Arbor, Michigan +1 locations
Conditions: Coronary Artery Disease, Cardiovascular Diseases, Smoking
TRISCEND II Pivotal Trial
Recruiting
Pivotal trial to evaluate the safety and effectiveness of the Edwards EVOQUE tricuspid valve replacement system
Gender:
All
Ages:
18 years and above
Trial Updated:
01/12/2024
Locations: SJHMC Heart and Vascular Institute, Phoenix, Arizona +64 locations
Conditions: Tricuspid Valve Regurgitation, Tricuspid Valve Insufficiency, Tricuspid Valve Disease, Heart Valve Diseases, Cardiovascular Diseases, Heart Failure
Cancer Survivor Cardiomyopathy Detection
Recruiting
The purpose of this study is to improve the cardiovascular care of adult cancer survivors. The goal is to obtain the data necessary to plan and develop a nation-wide network of a screening program that can help provide cost-effective and long-term monitoring.
Gender:
All
Ages:
Between 18 years and 99 years
Trial Updated:
01/11/2024
Locations: Mayo Clinic in Rochester, Rochester, Minnesota
Conditions: Cardiovascular Diseases, Cancer
Healthy Lifestyles After Cancer for Adolescents and Young Adults: A Program to Reduce Cardiovascular Risk Factors
Recruiting
There are close to 700,000 survivors of adolescent and young adult (AYA) cancer (aged 15 to 39 at diagnosis) in the US. Survivorship for AYAs is often complicated by long-term and late-effects. Cardiovascular disease (CVD), in particular, is a leading cause of death for cancer survivors and is a growing public health concern for survivors diagnosed as AYAs. Risk of CVD may be associated with treatment exposures and may be potentiated by weight gain and poor health behaviors. Healthy eating and p... Read More
Gender:
All
Ages:
Between 18 years and 39 years
Trial Updated:
01/08/2024
Locations: Duke University, Durham, North Carolina
Conditions: Cancer, Cardiovascular Diseases, Weight Management, Pain, Fatigue, Distress, Emotional, Physical Inactivity
Using Digital Data to Predict CHD
Recruiting
This project seeks to identify and characterize features derived from digital data (e.g. social media, online search, mobile media) which are associated with coronary heart disease (CHD) and related risk factors, and develop models that use digital data and conventional predictive models to predict CHD risk and health care utilization.
Gender:
All
Ages:
Between 30 years and 74 years
Trial Updated:
01/04/2024
Locations: University of Pennsylvania Health System, Philadelphia, Pennsylvania
Conditions: Cardiovascular Diseases
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
Recruiting
Cardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past two decades, they are still higher in Black adults than White adults. There are also persistent disparities in CVD risk factors with higher prevalence of obesity, hypertension, and diabetes in Black compared to White populations. In addition, CVD and risk factors are more prevalent in the residents of Louisiana compare... Read More
Gender:
All
Ages:
40 years and above
Trial Updated:
01/02/2024
Locations: Tulane University, New Orleans, Louisiana
Conditions: Cardiovascular Diseases, Hypertension, Diabetes, Hypercholesterolemia
Safety and Efficacy Study of reSept ASD Occluder for Treating Secundum ASD
Recruiting
Evaluation of the safety and efficacy of the reSept ASD Occluder to treat patients with clinically significant secundum atrial septal defect
Gender:
All
Ages:
84 years and below
Trial Updated:
12/21/2023
Locations: Children's Hospital of Los Angeles, Los Angeles, California +27 locations
Conditions: Heart Septal Defect, Heart Septal Defects, Atrial, Heart Defects, Congenital, Cardiovascular Abnormalities, Cardiovascular Diseases, Heart Diseases, Congenital Abnormalities
Dysphagia in Cardiac Surgical Patients
Recruiting
Although dysphagia is a known complication of cardiac surgery, risk factors and sensitive bedside clinical markers of dysphagia have not yet been identified. This longitudinal study will enroll 380 cardiac surgical patients and identify contributing risk factors of incident cases of dysphagia and identify sensitive bedside markers of dysphagia. Statistical modeling will produce two pragmatic clinical tools - a risk prediction model and a beside screening tool to improve care models.
Gender:
All
Ages:
Between 18 years and 90 years
Trial Updated:
12/20/2023
Locations: University of Florida, Gainesville, Florida +1 locations
Conditions: Cardiovascular Diseases, Dysphagia
Testing Promising Behavioral Economic Interventions to Promote Enrollment Diversity in Cardiovascular Cohort Studies
Recruiting
Problem. Randomized clinical trials (RCTs) are the best way to determine if interventions are safe and effective. Usually only a small number of eligible patients enroll. This is because trials require people to consent to be enrolled and randomized. Black and Hispanic people are more likely to develop heart disease. They are also more likely to have risk factors for heart disease that are not controlled. Yet they are very under-represented in heart disease trials. This raises concerns about if... Read More
Gender:
All
Ages:
18 years and above
Trial Updated:
12/20/2023
Locations: Penn Medicine, Philadelphia, Pennsylvania
Conditions: Cardiovascular Diseases